<p>One-way sensitivity analysis on incremental cost per quality-adjusted life-year (ICER) gained by dabigatran 150mg.</p
<p>One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.</p
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047473#pone-0047473-g003" ...
<p>Sensitivity analyses of cost-effectiveness results by age at time of treatment, cost of anti-HCV ...
<p>Sensitivity of the ICER to the cost of cetuximab per mg and the risk of progression in the cetuxi...
A univariable sensitivity analysis of the ICER for different parameters over the range for each para...
<p>All model parameters were analyzed, and only those with the highest relative effect on ICER are d...
<p>ICER, incremental cost-effectiveness ration; QALY, quality adjusted life years.</p
<p>Analyses of incremental cost-effectiveness ratios (ICERs) based on age and risk groups.</p
<p>Incremental Cost-Effectiveness ratios (ICER) are expressed in Euros per QALY gained (€/Q).</p><p>...
<p>Light grey bars denote influence of the high value of the 95% confidence interval range and dark ...
<p>Results of the cost effectiveness analysis according to incremental cost effectiveness ratio (ICE...
– DAA Treatment in the acute stage of infection is compared to delayed F2 DAA treatment with varying...
One- and two-way sensitivity analyses for the estimated annual direct cost of HF in each phenotype a...
Sensitivity analyses: Incremental total and per-member per-month (PMPM) costs (MYR) after one-year o...
*<p>See column sensitivity analysis in <a href="http://www.plosone.org/article/info:doi/10.1371/jour...
<p>One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.</p
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047473#pone-0047473-g003" ...
<p>Sensitivity analyses of cost-effectiveness results by age at time of treatment, cost of anti-HCV ...
<p>Sensitivity of the ICER to the cost of cetuximab per mg and the risk of progression in the cetuxi...
A univariable sensitivity analysis of the ICER for different parameters over the range for each para...
<p>All model parameters were analyzed, and only those with the highest relative effect on ICER are d...
<p>ICER, incremental cost-effectiveness ration; QALY, quality adjusted life years.</p
<p>Analyses of incremental cost-effectiveness ratios (ICERs) based on age and risk groups.</p
<p>Incremental Cost-Effectiveness ratios (ICER) are expressed in Euros per QALY gained (€/Q).</p><p>...
<p>Light grey bars denote influence of the high value of the 95% confidence interval range and dark ...
<p>Results of the cost effectiveness analysis according to incremental cost effectiveness ratio (ICE...
– DAA Treatment in the acute stage of infection is compared to delayed F2 DAA treatment with varying...
One- and two-way sensitivity analyses for the estimated annual direct cost of HF in each phenotype a...
Sensitivity analyses: Incremental total and per-member per-month (PMPM) costs (MYR) after one-year o...
*<p>See column sensitivity analysis in <a href="http://www.plosone.org/article/info:doi/10.1371/jour...
<p>One-way sensitivity analyses of the incremental cost-effectiveness of PrEP.</p
<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0047473#pone-0047473-g003" ...
<p>Sensitivity analyses of cost-effectiveness results by age at time of treatment, cost of anti-HCV ...
DOI
Add to ORKG